4
Changes in Ownership
Intellia Therapeutics, Inc. Filed Acc 0001209191-22-015976
EVP, Chief Scientific Officer sold 1,148 shares at $112.25 ($128,863)
- EVP, Chief Scientific Officer acquired 13,816 shares (grant or award)
- EVP, Chief Scientific Officer acquired 3,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Sepp-Lorenzino Laura · EVP, Chief Scientific Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-01 | Exercise or conversion : show line 1 in the form | +3,500 | 5,963 | D | ||
| 2022-01-01 | Sale : show line 2 in the form | −1,148 | $112.25 | $128,863 | 4,815 | D |
| 2022-03-01 | Grant or award : show line 3 in the form | +13,816 | 18,631 | D | ||
| Open-market sales · 1,148 sh · avg $112.25 · $128,863 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-01-01 | Exercise or conversion : show line 4 in the form Restricted Stock Unit | −3,500 | 10,500 | D |
| 2022-03-01 | Grant or award : show line 5 in the form Stock Option (right to buy) | +13,816 | 13,816 | D |
Loading xslF345X03/doc4.xml…